The Clinical Development Director (CDD) is part of the Global Oncology Therapeutic Area team and tovorafenib Global Asset team responsible and accountable for the development of the Clinical Development Plan (CDP) and the development of the Clinical Development Plan (CDP) and clinical aspects of the Integrated Development commercialization Plan (IDCP) of Ipsen's new products in oncology under the direction of the VP, Clinical Development oncology and in collaboration with Tovorafenib Asset Lead . It leads the Global Development Team Works in partnership with other global asset functions in accordance with Target Product Profiles (TPP) as jointly developed within the asset team .
This position:
Works closely with the global asset team cross-functionally : Early Development, Regulatory Affairs, Drug Safety, Medical Affairs, commercial Franchise Oncology in providing clinical support for the drug development program
Delivers high-quality scientific input and clinical interpretation on specific product data in fulfilment of the development business objectives for registration.
Provide pivotal clinical input to Ipsen's individual oncology drugs, including but not limited to recently acquired assets, and to support regional and/or global drug development.
Ensures from a clinical perspective compliance with GCP, ethical, scientific and medical guidelines and statutory principles throughout all clinical development activities.
Consistently works within complex medical situations under tight time constraints, prioritizing appropriately to deliver expected results.
Effectively manages relationships in a cross functional and matrix environment with internal and external stakeholders.
Advises Vice President R&D oncology and Tovorafenib Asset Lead on critical issues deserving immediate attention and escalation, proposing actionable solutions.
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.